All Stories

  1. Preeclampsia: Biological and Clinical Aspects

    Article • March 2022, Bentham Science Publishers

    Dr Everette Nelson, Dr Meganathan Kannan

  2. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients

    Article • Thrombosis and Haemostasis, February 2013, Schattauer GmbH

    Dr Meganathan Kannan

  3. Characterisation of mutations and molecular studies of type 2 von Willebrand disease

    Article • Thrombosis and Haemostasis, November 2012, Schattauer GmbH

    Dr Meganathan Kannan

  4. Omic Approaches to Quality Biomarkers for Stored Platelets: Are We There Yet?

    Article • Transfusion Medicine Reviews, July 2010, Elsevier

    Dr Meganathan Kannan

  5. Differential profiling of human red blood cells during storage for 52 selected microRNAs

    Article • Transfusion, February 2010, Wiley

    Dr Meganathan Kannan

  6. Coinheritance of Severe von Willebrand Disease With Glanzmann Thrombasthenia

    Article • Clinical and Applied Thrombosis/Hemostasis, February 2010, SAGE Publications

    Dr Meganathan Kannan

  7. Role of RFLP using TspRI for carrier detection in Glanzmann’s thrombasthenia: a report on two families

    Article • International Journal of Laboratory Hematology, February 2010, Wiley

    Dr Meganathan Kannan

  8. Impact of Thrombogenic Mutations on Clinical Phenotypes of von Willebrand Disease

    Article • Clinical and Applied Thrombosis/Hemostasis, December 2009, SAGE Publications

    Dr Meganathan Kannan

  9. Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia

    Article • Journal of Thrombosis and Haemostasis, November 2009, Wiley

    Dr Meganathan Kannan

  10. Acquired Glanzmann’s thrombasthenia associated with Hairy cell leukaemia

    Article • European Journal of Clinical Investigation, July 2009, Wiley

    Dr Meganathan Kannan

  11. Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis

    Article • Transfusion, July 2009, Wiley

    Dr Meganathan Kannan

  12. Modulation of clinical phenotype of Glanzmann's thrombasthenia by thrombogenic mutations

    Article • Clinica Chimica Acta, May 2009, Elsevier

    Dr Meganathan Kannan

  13. An Update on the Prevalence and Characterization of H-PF4 Antibodies in Asian-Indian Patients

    Article • Seminars in Thrombosis and Hemostasis, April 2009, Thieme Publishing Group

    Dr Meganathan Kannan

  14. Increased Prevalence of Antiheparin Platelet Factor 4 Antibodies in Patients May Be Due to Contaminated Heparin

    Article • Clinical and Applied Thrombosis/Hemostasis, April 2009, SAGE Publications

    Dr Meganathan Kannan

  15. Glanzmann's thrombasthenia in North Indians: Sub classification and carrier detection by flow cytometry

    Article • Platelets, January 2009, Taylor & Francis

    Dr Meganathan Kannan

  16. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease

    Article • Annals of Hematology, October 2008, Springer Science + Business Media

    Dr Meganathan Kannan

  17. Glanzmann's Thrombasthenia: An Overview

    Article • Clinical and Applied Thrombosis/Hemostasis, October 2008, SAGE Publications

    Dr Meganathan Kannan

  18. Carrier Detection in Glanzmann Thrombasthenia

    Article • American Journal of Clinical Pathology, July 2008, Oxford University Press (OUP)

    Dr Meganathan Kannan

  19. Inherited platelet function disorders versus other inherited bleeding disorders: An Indian overview

    Article • Thrombosis Research, January 2008, Elsevier

    Dr Meganathan Kannan

  20. Hypercoagulable State in Five Thalassemia Intermedia Patients

    Article • Clinical and Applied Thrombosis/Hemostasis, October 2007, SAGE Publications

    Dr Meganathan Kannan

  21. Laboratory studies in coagulation disorders

    Article • The Indian Journal of Pediatrics, July 2007, Springer Science + Business Media

    Dr Meganathan Kannan

  22. Disseminated Intravascular Coagulation in Acute Leukemia at Presentation and During Induction Therapy

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2007, SAGE Publications

    Dr Meganathan Kannan

  23. Gene tracking in a family of novel identical twins affected by severe type-III von Willebrand Disease (vWD)

    Article • Thrombosis Research, January 2007, Elsevier

    Dr Meganathan Kannan

  24. Prenatal diagnosis of haemophilia A by chorionic villus sampling and cordocentesis: All India Institute of Medical Science experience

    Article • Vox Sanguinis, January 2007, Wiley

    Dr Meganathan Kannan

  25. Acquired von Willebrand's disease associated with gastrointestinal angiodysplasia: a case report

    Article • Haemophilia, July 2006, Wiley

    Dr Meganathan Kannan

  26. Use of Intron 1 and 22 inversions and linkage analysis in carrier detection of hemophilia A in Indians

    Article • Clinica Chimica Acta, March 2006, Elsevier

    Dr Meganathan Kannan

  27. Roles of protein C, protein S, and antithrombin III in acute leukemia

    Article • American Journal of Hematology, January 2006, Wiley

    Dr Meganathan Kannan

  28. Congenital vitamin K-dependent coagulation factor deficiency: a case report

    Article • Blood Coagulation & Fibrinolysis, October 2005, Wolters Kluwer Health

    Dr Meganathan Kannan

  29. Functional characterization of antibodies against heparin–platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers

    Article • Blood Coagulation & Fibrinolysis, October 2005, Wolters Kluwer Health

    Dr Meganathan Kannan

  30. Gene conversions are a common cause of von Willebrand disease

    Article • British Journal of Haematology, September 2005, Wiley

    Dr Meganathan Kannan

  31. First report of a FVII-deficient Indian patient carrying double heterozygous mutations in the FVII gene

    Article • Thrombosis Research, January 2005, Elsevier

    Dr Meganathan Kannan

  32. Heparin-PF4 Antibodies in Heparin Induced Thrombocytopenia: Its Relationship with FcgRIIa Polymorphism

    Article • American Journal of Immunology, January 2005, Science Publications

    Dr Meganathan Kannan

  33. Protein C system defects in Indian children with thrombosis

    Article • Annals of Hematology, September 2004, Springer Science + Business Media

    Dr Meganathan Kannan

  34. Carrier detection in severe von Willebrand?s disease

    Article • Annals of Hematology, August 2004, Springer Science + Business Media

    Dr Meganathan Kannan

  35. Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease

    Article • Annals of Hematology, July 2004, Springer Science + Business Media

    Dr Meganathan Kannan

  36. Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis : A Study From North India

    Article • American Journal of Clinical Pathology, June 2004, Oxford University Press (OUP)

    Dr Meganathan Kannan

  37. Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis

    Article • American Journal of Clinical Pathology, June 2004, Oxford University Press (OUP)

    Dr Meganathan Kannan

  38. Laboratory Diagnosis of Heparin-Induced Thrombocytopenia in Asian Indians as Investigated With Functional and Immunologic Methods

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2004, SAGE Publications

    Dr Meganathan Kannan

  39. Neonatal thrombosis

    Article • The Indian Journal of Pediatrics, November 2003, Springer Science + Business Media

    Dr Meganathan Kannan

  40. Pro CR Global: An effective screening test for thrombophilia

    Article • American Journal of Hematology, October 2003, Wiley

    Dr Meganathan Kannan

  41. Type I Glanzmann thrombasthenia: Most common subtypes in North Indians

    Article • American Journal of Hematology, September 2003, Wiley

    Dr Meganathan Kannan

  42. Mutation reports: Intron 1 and 22 inversions in Indian haemophilics

    Article • Annals of Hematology, September 2003, Springer Science + Business Media

    Dr Meganathan Kannan

  43. Factor V Leiden—the commonest molecular defect in arterial and venous thrombophilia in India

    Article • Thrombosis Research, April 2003, Elsevier

    Dr Meganathan Kannan

  44. Does the MTHFR 677T allele alter the clinical phenotype in severe haemophilia A?

    Article • Thrombosis Research, January 2003, Elsevier

    Dr Meganathan Kannan

  45. Neonatal thrombosis in India: a report of 14 cases

    Article • Thrombosis Research, January 2003, Elsevier

    Dr Meganathan Kannan